209 related articles for article (PubMed ID: 21693658)
21. Adipogenesis induces growth inhibition of dedifferentiated liposarcoma.
Kim YJ; Yu DB; Kim M; Choi YL
Cancer Sci; 2019 Aug; 110(8):2676-2683. PubMed ID: 31069877
[TBL] [Abstract][Full Text] [Related]
22. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
[TBL] [Abstract][Full Text] [Related]
23. Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.
Shin CH; Lee H; Kim HR; Choi KH; Joung JG; Kim HH
Cell Death Differ; 2017 Nov; 24(11):1861-1871. PubMed ID: 28708135
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
Creytens D; Van Gorp J; Speel EJ; Ferdinande L
Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA PTPRG-AS1 acts as a microRNA-194-3p sponge to regulate radiosensitivity and metastasis of nasopharyngeal carcinoma cells via PRC1.
Yi L; Ouyang L; Wang S; Li SS; Yang XM
J Cell Physiol; 2019 Aug; 234(10):19088-19102. PubMed ID: 30993702
[TBL] [Abstract][Full Text] [Related]
26. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway.
Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G
Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974
[TBL] [Abstract][Full Text] [Related]
27. Silencing of perilipin by short hairpin RNA inhibits proliferation and induces apoptosis in liposarcoma cells.
Meng LX; Zheng YX; He ML; Zhou XM; Sun SY; Ding ZJ; Meng Q; Li BC; Sun YW
Mol Med Rep; 2018 Nov; 18(5):4571-4576. PubMed ID: 30221658
[TBL] [Abstract][Full Text] [Related]
28. Gene expression profiling of liposarcoma identifies distinct biological types/subtypes and potential therapeutic targets in well-differentiated and dedifferentiated liposarcoma.
Singer S; Socci ND; Ambrosini G; Sambol E; Decarolis P; Wu Y; O'Connor R; Maki R; Viale A; Sander C; Schwartz GK; Antonescu CR
Cancer Res; 2007 Jul; 67(14):6626-36. PubMed ID: 17638873
[TBL] [Abstract][Full Text] [Related]
29. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
[TBL] [Abstract][Full Text] [Related]
30. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
31. Liposarcoma: molecular targets and therapeutic implications.
Bill KL; Casadei L; Prudner BC; Iwenofu H; Strohecker AM; Pollock RE
Cell Mol Life Sci; 2016 Oct; 73(19):3711-8. PubMed ID: 27173057
[TBL] [Abstract][Full Text] [Related]
32. Microarray-based copy number and expression profiling in dedifferentiated and pleomorphic liposarcoma.
Fritz B; Schubert F; Wrobel G; Schwaenen C; Wessendorf S; Nessling M; Korz C; Rieker RJ; Montgomery K; Kucherlapati R; Mechtersheimer G; Eils R; Joos S; Lichter P
Cancer Res; 2002 Jun; 62(11):2993-8. PubMed ID: 12036902
[TBL] [Abstract][Full Text] [Related]
33. miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.
Vo DT; Karanam NK; Ding L; Saha D; Yordy JS; Giri U; Heymach JV; Story MD
Neoplasia; 2019 Sep; 21(9):849-862. PubMed ID: 31325708
[TBL] [Abstract][Full Text] [Related]
34. Liposarcoma miRNA signatures identified from genome-wide miRNA expression profiling.
Zhou Y; Zhang Y; Huang Y; Tan R; Liu T; Zhuang R; Zhu M; Han W; Hou Y; Liu J; Zhang L; Jiang Y; Tong H; Shao Y; Zhu J; Lu W
Future Oncol; 2014 Jun; 10(8):1373-86. PubMed ID: 25052748
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA profiling reveals dysregulated microRNAs and their target gene regulatory networks in cemento-ossifying fibroma.
Pereira TDSF; Brito JAR; Guimarães ALS; Gomes CC; de Lacerda JCT; de Castro WH; Coimbra RS; Diniz MG; Gomez RS
J Oral Pathol Med; 2018 Jan; 47(1):78-85. PubMed ID: 29032608
[TBL] [Abstract][Full Text] [Related]
36. The emerging roles and therapeutic potential of microRNAs (miRs) in liposarcoma.
Sun R; Shen JK; Choy E; Yu Z; Hornicek FJ; Duan Z
Discov Med; 2015 Nov; 20(111):311-24. PubMed ID: 26645903
[TBL] [Abstract][Full Text] [Related]
37. Lipomatous tumors.
Weiss SW
Monogr Pathol; 1996; 38():207-39. PubMed ID: 8744279
[TBL] [Abstract][Full Text] [Related]
38. Intraperitoneal dedifferentiated liposarcoma: a case report.
Karaman A; Kabalar ME; Ozcan O; Koca T; Binici DN
World J Gastroenterol; 2008 Oct; 14(38):5927-9. PubMed ID: 18855997
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-26a regulates tumorigenic properties of EZH2 in human lung carcinoma cells.
Dang X; Ma A; Yang L; Hu H; Zhu B; Shang D; Chen T; Luo Y
Cancer Genet; 2012 Mar; 205(3):113-23. PubMed ID: 22469510
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
